Abstract Churg–Strauss syndrome (CSS), alternatively known as eosinophilic
granulomatosis with polyangiitis (EGPA), was first described in 1951 by Churg and Strauss …

Recently, a group of experts in the field suggested to rename Churg–Strauss syndrome as
eosinophilic granulomatosis with polyangiitis (EGPA). This condition, first described in 1951 …

Eosinophilic granulomatosis with polyangiitis (EGPA), formerly called Churg–Strauss
syndrome, is a systemic necrotizing vasculitis of small-and medium-size vessels …

Objectives. To study the clinical spectrum and evolution of Churg–Strauss syndrome in order
to assess the clinicopathological features of the disease, the response to treatment and the …

Abstract Objective. Churg–Strauss syndrome is a rare multisystem vasculitis of unknown
aetiology. Due to the rarity of the disease, few single‐centre case series have been …

Churg-Strauss syndrome (CSS) is a systemic necrotizing vasculitis named after the two
pathologists, Churg and Strauss, who first described the disease in 1951. 1 In their original …

Objective To assess the efficacy of systemic corticosteroids (CS) alone as first‐line treatment
in patients with Churg‐Strauss syndrome (CSS) without poor‐prognosis factors, as defined …

Eosinophilic granulomatosis with polyangiitis (EGPA) is a rare, multi-system, inflammatory
disease, belonging to the group of anti-neutrophil cytoplasmic antibody (ANCA)-associated …

Churg-Strauss-Syndrome (CSS) often takes a mild course and is in many cases treated
successfully by glucocorticosteroids (GC) alone. However, there are also several reports …

abstract Eosinophilic granulomatosis with polyangiitis (EGPA)(formerly Churg-Strauss
syndrome) is a rare form of anti-neutrophil cytoplasm antibody (ANCA)-associated vasculitis …